Preventive Medicine, Public Health & General Preventive Medicine · San Bernardino, CA
NPI
1669534293
Since 2006
Specialty
Preventive Medicine, Public Health & General Preventive Medicine
Code 2083P0901X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
799 E Rialto Ave
San Bernardino, CA, 92415
Phone (909) 383-3060
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.0M
1,377 prescriptions
Company payments, 2025
$5,639
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ryan Zane prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 267 prescriptions and refills. In total Ryan Zane wrote 1,377 Medicare prescriptions that cost $4.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 267 | 285 | 38 | $1.1M |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 138 | 164 | 19 | $750K |
| Tivicay Dolutegravir Sodium | 132 | 140 | 16 | $304K |
| Prezcobix Darunavir/Cobicistat | 121 | 137 | 13 | $336K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 106 | 117 | 16 | $469K |
| Dovato Dolutegravir Sodium/Lamivudine | 60 | 60 | Under 11 | $185K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 53 | 53 | Under 11 | $190K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 48 | 50 | Under 11 | $168K |
| Cabenuva Cabotegravir/Rilpivirine | 38 | 68 | Under 11 | $252K |
| Descovy Emtricitabine/Tenofov Alafenam | 37 | 43 | Under 11 | $90K |
| Atorvastatin Calcium Generic | 32 | 32 | Under 11 | $80.55 |
| Darunavir Generic | 24 | 24 | Under 11 | $22K |
| Rifampin Generic | 22 | 22 | Under 11 | $624 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 22 | Under 11 | $72.74 |
| Isentress Raltegravir Potassium | 19 | 19 | Under 11 | $41K |
Brand drugs: 1,038 claims; generic drugs: 339 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan Zane $5,639 ($5,639 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $5,639.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 7 | $5,639 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.